Anzahl der Publikationen: 19
2022
Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg und Harbeck, Nadia
(2022):
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
In: Breast Cancer Research, Bd. 24, Nr. 1, 58
de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia
(2022):
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724
Grote, Isabel; Bartels, Stephan; Christgen, Henriette; Radner, Martin; Gronewold, Malte; Kandt, Leonie; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans und Christgen, Matthias
(2022):
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
In: Modern Pathology, Bd. 35, Nr. 12: S. 1804-1811
2021
Jurmeister, Philipp; Vollbrecht, Claudia; Joehrens, Korinna; Aust, Daniela; Behnke, Anke; Stenzinger, Albrecht; Penzel, Roland; Endris, Volker; Schirmacher, Peter; Fisseler-Eckhoff, Annette; Neumann, Jens; Kirchner, Thomas; Buettner, Reinhard; Merkelbach-Bruse, Sabine; Kreipe, Hans; Jonigk, Danny; Jochum, Wolfram; Rodriguez, Regulo; Dietel, Manfred; Horst, David; Hummel, Michael und Laffert, Maximilian von
(2021):
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing.
In: Virchows Archiv, Bd. 479, Nr. 2: S. 247-255
Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kuemmel, Sherko; Zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias und Kreipe, Hans
(2021):
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
In: Cancer Medicine, Bd. 10, Nr. 23: S. 8581-8594
Christgen, Matthias; Kandt, Leonie Donata; Antonopoulos, Wiebke; Bartels, Stephan; Bockstal, Mieke R. van; Bredt, Martin; Brito, Maria Jose; Christgen, Henriette; Colpaert, Cecile; Cserni, Balint; Cserni, Gabor; Daemmrich, Maximilian E.; Danebrock, Raihanatou; Dedeurwaerdere, Franceska; Deurzen, Carolien H. M. van; Erber, Ramona; Fathke, Christine; Feist, Henning; Fiche, Maryse; Gonzalez, Claudia Aura; Hoeve, Natalie D. ter; Kooreman, Loes; Krech, Till; Kristiansen, Glen; Kulka, Janina; Laenger, Florian; Lafos, Marcel; Lehmann, Ulrich; Martin-Martinez, Maria Dolores; Mueller, Sophie; Pelz, Enrico; Raap, Mieke; Ravarino, Alberto; Reineke-Plaass, Tanja; Schaumann, Nora; Schelfhout, Anne-Marie; Schepper, Maxim de; Schlue, Jerome; Vijver, Koen van de; Waelput, Wim; Wellmann, Axel; Graeser, Monika; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Desmedt, Christine; Floris, Giuseppe; Derksen, Patrick W. B.; Diest, Paul J. van; Vincent-Salomon, Anne und Kreipe, Hans
(2021):
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
In: Journal of Pathology Clinical Research, Bd. 8, Nr. 2: S. 191-205
2020
Dowsett, Mitch; Ellis, Matthew J. ORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2020):
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10
[PDF, 1MB]
Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galvan, Patricia; Barbera, Laura; Cuatrecasas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge-Escartin, Ines; Villagrasa, Patricia; Soy, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina und Prat, Aleix
(2020):
ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
In: Cancers, Bd. 12, Nr. 7, 1902
Kolberg-Liedtke, Cornelia; Gluz, Oleg; Heinisch, Fred; Feuerhake, Friedrich; Kreipe, Hans; Clemens; Nuding, Benno; Malter, Wolfram; Reimer, Tora; Würstlein, Rachel; Graeser, Monika; Shak, Steve; Nitz, Ulrike; Kates, Ronald; Christgen, Matthias und Harbeck, Nadia
(2020):
Association of TILs with clinical parameters, Recurrence Score (R) results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 47
Kirchner, Martina; Glade, Julia; Lehmann, Ulrich; Merkelbach-Bruse, Sabine; Hummel, Michael; Lehmann, Annika; Trautmann, Marcel; Kumbrink, Jorg; Jung, Andreas; Dietmaier, Wolfgang; Endris, Volker; Kazdal, Daniel; Ploeger, Carolin; Evert, Matthias; Horst, David; Kreipe, Hans; Kirchner, Thomas; Wardelmann, Eva; Buettner, Reinhard; Weichert, Wilko; Dietel, Manfred; Schirmacher, Peter; Stenzinger, Albrecht und Pfarr, Nicole
(2020):
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays.
In: Genes Chromosomes & Cancer, Bd. 59, Nr. 8: S. 445-453
Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Frederick; Würstlein, Rachel; Nitz, Ulrike und Kreipe, Hans
(2020):
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
In: Cancer, Bd. 126, Nr. 22: S. 4847-4858
2019
Pfarr, Nicole; Kirchner, Martina; Lehmann, Ulrich; Leichsenring, Jonas; Merkelbach-Bruse, Sabine; Glade, Julia; Hummel, Michael; Stoegbauer, Fabian; Lehmann, Annika; Trautmann, Marcel; Kumbrink, Jörg; Jung, Andreas; Dietmaier, Wolfgang; Endris, Volker; Kazdal, Daniel; Evert, Matthias; Horst, David; Kreipe, Hans; Kirchner, Thomas; Wardelmann, Eva; Lassen, Ulrik; Buettner, Reinhard; Weichert, Wilko; Dietel, Manfred; Schirmacher, Peter und Stenzinger, Albrecht
(2019):
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
In: Genes Chromosomes & Cancer, Bd. 59, Nr. 3: S. 178-188
Christgen, Matthias; Bartels, Stephan; Radner, Martin; Raap, Mieke; Rieger, Luisa; Christgen, Henriette; Gluz, Oleg; Nitz, Ulrike; Harbeck, Nadia; Lehmann, Ulrich und Kreipe, Hans
(2019):
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling.
In: Genes Chromosomes & Cancer, Bd. 58, Nr. 3: S. 175-185
2017
Kampers, Johanna; Orjuela-Grimm, Manuela; Schober, Tilmann; Schulz, Thomas F.; Stiefel, Martina; Klein, Christoph; Körholz, Dieter; Mauz-Körholz, Christine; Kreipe, Hans; Beier, Rita und Maecker-Kolhoff, Britta
(2017):
Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
In: Leukemia & Lymphoma, Bd. 58, Nr. 3: S. 633-638
2016
Endris, Volker; Stenzinger, Albrecht; Pfarr, Nicole; Penzel, Roland; Möbs, Markus; Lenze, Dido; Darb-Esfahani, Silvia; Hummel, Michael; Merkelbach-Bruse, Sabine; Jung, Andreas; Lehmann, Ulrich; Kreipe, Hans; Kirchner, Thomas; Büttner, Reinhard; Jochum, Wolfram; Höfler, Gerald; Dietel, Manfred; Weichert, Wilko und Schirmacher, Peter
(2016):
NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.
In: Virchows Archiv, Bd. 468, Nr. 6: S. 697-705
Höckendorf, Ulrike; Yabal, Monica; Herold, Tobias; Munkhbaatar, Enkhtsetseg; Rott, Stephanie; Jilg, Stefanie; Kauschinger, Johanna; Magnani, Giovanni; Reisinger, Florian; Heuser, Michael; Kreipe, Hans; Sotlar, Karl; Engleitner, Thomas; Rad, Roland; Weichert, Wilko; Peschel, Christian; Ruland, Jürgen; Heikenwalder, Mathias; Spiekermann, Karsten; Slotta-Huspenina, Julia; Groß, Olaf und Jost, Philipp J.
(2016):
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells.
In: Cancer Cell, Bd. 30, Nr. 1: S. 75-91
Christgen, Matthias; Steinemann, Doris; Kühnle, Elna; Länger, Florian; Gluz, Oleg; Harbeck, Nadia und Kreipe, Hans
(2016):
Lobular breast cancer: Clinical, molecular and morphological characteristics.
In: Pathology Research and Practice, Bd. 212, Nr. 7: S. 583-597
2013
Diese Liste wurde am
Sat Nov 23 22:29:27 2024 CET
erstellt.